Dolutegravir Plus Lamivudine for Maintenance of HIV Viral Suppression in Adults with and Without Historical Resistance to Lamivudine: 48-Week Results of a Non-Randomized, Pilot Clinical Trial (ART-PRO)
EBioMedicine(2020)
关键词
Antiviral Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要